van den Bergh H - Search Results

1

A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV.

Lange N, Ballini JP, Wagnieres G, van den Bergh H. Lange N, et al. Among authors: van den bergh h. Invest Ophthalmol Vis Sci. 2001 Jan;42(1):38-46. Invest Ophthalmol Vis Sci. 2001. PMID: 11133846

2

Processing of fluorescence angiograms for the quantification of vascular effects induced by anti-angiogenic agents in the CAM model.

Nowak-Sliwinska P, Ballini JP, Wagnières G, van den Bergh H. Nowak-Sliwinska P, et al. Among authors: van den bergh h. Microvasc Res. 2010 Jan;79(1):21-8. doi: 10.1016/j.mvr.2009.10.004. Epub 2009 Oct 24. Microvasc Res. 2010. PMID: 19857502

3

Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy.

Glanzmann T, Hadjur C, Zellweger M, Grosiean P, Forrer M, Ballini JP, Monnier P, van den Bergh H, Lim CK, Wagnières G. Glanzmann T, et al. Among authors: van den bergh h. Photochem Photobiol. 1998 May;67(5):596-602. Photochem Photobiol. 1998. PMID: 9613244 Clinical Trial.

4

A computer-based method to quantify the classic pattern of choroidal neovascularization in order to monitor photodynamic therapy.

Sickenberg M, Ballini JP, van den Bergh H. Sickenberg M, et al. Among authors: van den bergh h. Graefes Arch Clin Exp Ophthalmol. 1999 May;237(5):353-60. doi: 10.1007/s004170050244. Graefes Arch Clin Exp Ophthalmol. 1999. PMID: 10333100 Clinical Trial.

5

On the selectivity of photodynamic therapy of choroidal neovascularization associated with age-related macular degeneration.

van den Bergh H, Ballini JP, Sickenberg M. van den Bergh H, et al. J Fr Ophtalmol. 2004 Jan;27(1):75-8. doi: 10.1016/s0181-5512(04)96097-4. J Fr Ophtalmol. 2004. PMID: 14968083

6

Combination therapy using aspirin-enhanced photodynamic selective drug delivery.

Debefve E, Pegaz B, Ballini JP, Konan YN, van den Bergh H. Debefve E, et al. Among authors: van den bergh h. Vascul Pharmacol. 2007 Mar;46(3):171-80. doi: 10.1016/j.vph.2006.09.006. Epub 2006 Sep 29. Vascul Pharmacol. 2007. PMID: 17112789

7

Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model.

Debefve E, Pegaz B, van den Bergh H, Wagnières G, Lange N, Ballini JP. Debefve E, et al. Among authors: van den bergh h. Angiogenesis. 2008;11(3):235-43. doi: 10.1007/s10456-008-9106-4. Epub 2008 Mar 7. Angiogenesis. 2008. PMID: 18324477 Free PMC article.

8

Protoporphyrin IX photodynamic therapy for synovitis.

Kirdaite G, Lange N, Busso N, Van Den Bergh H, Kucera P, So A. Kirdaite G, et al. Among authors: van den bergh h. Arthritis Rheum. 2002 May;46(5):1371-8. doi: 10.1002/art.10199. Arthritis Rheum. 2002. PMID: 12115245 Free article.

9

Time-dependent hexaminolaevulinate induced protoporphyrin IX distribution after topical application in patients with cervical intraepithelial neoplasia: A fluorescence microscopy study.

Andrejevic-Blant S, Major A, Lüdicke F, Ballini JP, Wagnières G, van den Bergh H, Pelte MF. Andrejevic-Blant S, et al. Among authors: van den bergh h. Lasers Surg Med. 2004;35(4):276-83. doi: 10.1002/lsm.20095. Lasers Surg Med. 2004. PMID: 15493027

10

Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos.

Vargas A, Pegaz B, Debefve E, Konan-Kouakou Y, Lange N, Ballini JP, van den Bergh H, Gurny R, Delie F. Vargas A, et al. Among authors: van den bergh h. Int J Pharm. 2004 Nov 22;286(1-2):131-45. doi: 10.1016/j.ijpharm.2004.07.029. Int J Pharm. 2004. PMID: 15501010

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters